You can find the annual or quarterly income statement of Salarius Pharmaceuticals Ord Shs here for insights into the performance and operational efficiency of Salarius Pharmaceuticals Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

Operating expenses

--2.28M

--516.60K

--895.13K

R&D expenses

--749.81K

--114.43K

--61.83K

Depreciation, depletion, and amortization

--5.92K

--3.83K

--1.11K

Operating profit

---2.28M

---516.60K

---895.13K

Net non-operating interest income (expenses)

Non-operating interest income

--59.11K

--56.91K

--21.66K

Special income (expenses)

----

---8.52M

----

Other non-operating income (expenses)

--59.11K

--56.91K

----

Income before tax

---2.22M

---8.98M

---873.47K

Income tax

----

--0.00

----

Income after tax

---2.22M

---8.98M

---873.47K

Net income from continuous operations

---2.22M

---8.98M

---873.47K

Net Income attributable to non-controlling interests

--0.00

----

Net income attributable to controlling interests

---2.22M

---8.98M

---873.47K

Net income attributable to common shareholders

---2.22M

---8.98M

---873.47K

Basic earnings per share

---602.19

---305.75

---21.76

Diluted earnings per share

---602.19

---305.75

---21.76

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

